Methotrexate for Injection USP

Published Online: Thursday, December 1, 2005
Follow Pharmacy_Times:

Bedford Laboratories (Bedford, Ohio), a division of Ben Venue Laboratories Inc, recently added Methotrexate for Injection USP, 1 g, to its line of oncology products. Methotrexate for Injection USP is indicated for the treatment of certain neoplastic diseases, severe psoriasis, and adult rheumatoid arthritis. The product is supplied in 4 singledose, preservative-free liquid presentations, containing 25 mg/mL of methotrexate sodium?50 mg in 2 mL, 100 mg in 4 mL, 200 mg in 8 mL, 250 mg in 10 mL?and in a 1- g single-dose, preservative-free lyophilized powder. For more information, visit www.bedfordlabs.com, or call 800-521-5169.



Related Articles
No Result Found
Latest Issues
$auto_registration$